These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 6124726)
41. Control of group C meningococcal disease in Australian aboriginal children by mass rifampicin chemoprophylaxis and vaccination. Pearce MC; Sheridan JW; Jones DM; Lawrence GW; Murphy DM; Masutti B; McCosker C; Douglas V; George D; O'Keefe A Lancet; 1995 Jul; 346(8966):20-3. PubMed ID: 7603139 [TBL] [Abstract][Full Text] [Related]
42. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine. Xie O; Pollard AJ; Mueller JE; Norheim G Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866 [TBL] [Abstract][Full Text] [Related]
43. Microbiological and epidemiological investigation of the Neisseria meningitidis serogroup A epidemic in Niger in 2009: last wave before the introduction of the serogroup A meningococcal conjugate vaccine? Collard JM; Maman Z; Abani A; Mainasara HB; Djibo S; Yacouba H; Maitournam R; Sidikou F; Nicolas P; Rocourt J; Jusot JF Epidemiol Infect; 2011 Nov; 139(11):1656-60. PubMed ID: 21251346 [TBL] [Abstract][Full Text] [Related]
44. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. Peltola H; Mäkelä H; Käyhty H; Jousimies H; Herva E; Hällström K; Sivonen A; Renkonen OV; Pettay O; Karanko V; Ahvonen P; Sarna S N Engl J Med; 1977 Sep; 297(13):686-91. PubMed ID: 408682 [TBL] [Abstract][Full Text] [Related]
45. Meningococcal meningitis: vaccination outbreak response and epidemiological changes in the African meningitis belt. Carod Artal FJ Int Health; 2015 Jul; 7(4):226-7. PubMed ID: 25878213 [TBL] [Abstract][Full Text] [Related]
46. A hypothetical explanatory model for meningococcal meningitis in the African meningitis belt. Mueller JE; Gessner BD Int J Infect Dis; 2010 Jul; 14(7):e553-9. PubMed ID: 20018546 [TBL] [Abstract][Full Text] [Related]
47. Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines. Robbins JB; Schneerson R; Gotschlich EC; Mohammed I; Nasidi A; Chippaux JP; Bernardino L; Maiga MA Bull World Health Organ; 2003; 81(10):745-50; discussion 751-5. PubMed ID: 14758435 [TBL] [Abstract][Full Text] [Related]
48. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic]. Wu C Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683 [No Abstract] [Full Text] [Related]
49. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Bjune G; Høiby EA; Grønnesby JK; Arnesen O; Fredriksen JH; Halstensen A; Holten E; Lindbak AK; Nøkleby H; Rosenqvist E Lancet; 1991 Nov; 338(8775):1093-6. PubMed ID: 1682541 [TBL] [Abstract][Full Text] [Related]
50. Pattern of the meningococcal meningitis outbreak in Northern Nigeria, 2009. Bassey BE; Vaz RG; Gasasira AN; Braka F; Weldegriebriel G; Komakech W; Toritseju MS; Fatiregun AA; Okocha-Ejeko A Int J Infect Dis; 2016 Feb; 43():62-67. PubMed ID: 26724773 [TBL] [Abstract][Full Text] [Related]
51. Outbreak of group C meningococcal disease in Australian Aboriginal children. Booy R Lancet; 1995 Aug; 346(8974):572-3. PubMed ID: 7658793 [No Abstract] [Full Text] [Related]
52. Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution. Marc LaForce F; Ravenscroft N; Djingarey M; Viviani S Vaccine; 2009 Jun; 27 Suppl 2():B13-9. PubMed ID: 19477559 [TBL] [Abstract][Full Text] [Related]
53. Time delays in the response to the Neisseria meningitidis serogroup C outbreak in Nigeria - 2017. Hassan A; Mustapha GU; Lawal BB; Na'uzo AM; Ismail R; Womi-Eteng Oboma E; Oyebanji O; Agenyi J; Thomas C; Balogun MS; Dalhat MM; Nguku P; Ihekweazu C PLoS One; 2018; 13(6):e0199257. PubMed ID: 29920549 [TBL] [Abstract][Full Text] [Related]
54. Intercountry meningitis meeting: preparing for the next epidemic seasons, Mali, October 2006. Wkly Epidemiol Rec; 2007 Feb; 82(5):34-40. PubMed ID: 17274150 [No Abstract] [Full Text] [Related]
55. A severe epidemic of meningococcal meningitis in Nigeria, 1996. Mohammed I; Nasidi A; Alkali AS; Garbati MA; Ajayi-Obe EK; Audu KA; Usman A; Abdullahi S Trans R Soc Trop Med Hyg; 2000; 94(3):265-70. PubMed ID: 10974995 [TBL] [Abstract][Full Text] [Related]
56. [Meningococcal disease in the Netherlands: media hype, but not an epidemic]. van Furth AM; Zaaijer HL Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1716-8. PubMed ID: 11572168 [TBL] [Abstract][Full Text] [Related]
57. Control of epidemic group A meningococcal meningitis in Nepal. Cochi SL; Markowitz LE; Joshi DD; Owens RC; Stenhouse DH; Regmi DN; Shrestha RP; Lacharya I; Manandhar M; Gurubacharya VL Int J Epidemiol; 1987 Mar; 16(1):91-7. PubMed ID: 3570627 [TBL] [Abstract][Full Text] [Related]
58. Control of epidemic meningococcal meningitis by mass vaccination. II. Persistence of antibody four years after vaccination. Mohammed I; Onyemelukwe GC; Obineche EN; Gupta N; Oyeyinka GO J Infect; 1984 Sep; 9(2):197-202. PubMed ID: 6438245 [TBL] [Abstract][Full Text] [Related]
59. [Meningococcal meningitis epidemics in sub-Saharan Africa and the meningococcal A conjugate vaccine]. Nicolas P Med Sante Trop; 2012; 22(3):246-58. PubMed ID: 23186941 [TBL] [Abstract][Full Text] [Related]
60. [Application of SP-RIA in the antibody surveillance and serologic diagnosis of epidemic cerebrospinal meningitis]. Chen X Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Dec; 14(6):366-70. PubMed ID: 8156584 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]